Lipoprotein(a) as an Alarming New Cardiovascular Risk Factor - Consequences on Clinical Practises
Deadline 2026-10-31Taylor & FrancisIndexed (Active)
Journal: Annals of Medicine
Lipoprotein (a) [Lp(a)] is an atherogenic lipoprotein particle structurally similar to low-density lipoprotein (LDL). Thus, its surface contains a single molecule of apolipoprotein B-100 (apo B-100) and phospholipids, and its core is filled with cholesterol. Uniquely, a large glycoprotein, apolipoprotein(a), is linked to the apo B-100, and a fraction of the phospholipids are oxidized (ox-PLs). By entering the arteri…
B Cells: Driver of Autoimmunity
Deadline 2026-11-30Taylor & FrancisIndexed (Active)
Journal: Annals of Medicine
B cells are key players in the adaptive immune system by presenting antigens to T cells, producing antibodies, and secreting pro-inflammatory cytokines. The production of autoantibodies by B cells is due to a defect in central tolerance; hence, targeting self-antigens makes them a central molecule to regulate autoimmunity. Different B cell therapies have been developed using rituximab and type II new anti-CD22 antib…
Integrative Neuromuscular Science Training and Musculoskeletal Health Across the Lifespan
Deadline 2026-11-30Taylor & FrancisIndexed (Active)
Journal: Annals of Medicine
Neuromuscular function and musculoskeletal health are the foundations of human movement, physical performance, and independence throughout life. From birth to old age, the integrity of muscle-tendon units, connective tissues, and brain control systems is crucial for effective force generation, coordination, and adaptability to physical demands. Alterations in neuromuscular function can occur due to aging, insufficie…
Patient Perspectives in Oncology
Deadline 2027-05-28Taylor & FrancisIndexed (Active)
Journal: Annals of Medicine
Patient perspectives remain underrepresented in oncology research and cancer policy, where outcomes are often defined by tumour response, survival, and treatment efficacy. While these measures are essential, they do not fully capture how cancer shapes the lived experience of patients. Individuals navigate uncertainty, symptom burden, complex decision making, disrupted family and work roles, and ongoing psychological…
Biomarkers in Neonatal and Pediatric Care
Deadline 2027-06-30Taylor & FrancisIndexed (Active)
Journal: Annals of Medicine
Over the past decades, pediatric research has focused on a wide spectrum of heterogeneous, often rare disorders occurring across all stages of childhood, from the neonatal period to adolescence. Significant efforts have been devoted to the identification and validation of candidate biomarkers, with the aim of improving understanding of disease pathophysiology, supporting diagnostic processes, refining phenotypic str…
Reference integrity note: verify every citation against the original source before submission, including publication year, journal title, volume/issue, page range, DOI, and the target journal style.